ConductScience.org, home

Paper36949199

RHOJ controls EMT-associated resistance to chemotherapy.

Debaugnies M and 17 others. Nature, 2023. Cited by 179 papers, by iCite.

Cite this record

ConductScience Library. RHOJ controls EMT-associated resistance to chemotherapy. Papers, record 36949199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36949199

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RHOJ controls EMT-associated resistance to chemotherapy.
PubMed
Journal
Nature
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
179
iCite
Relative citation ratio, by iCite
14.2
iCite
Revised in PubMed
2023-11-25
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Debaugnies MMaud
2Rodríguez-Acebes SSarahttps://orcid.org/0000-0002-9867-7591
3Blondeau JJeremy
4Parent MAMarie-Astrid
5Zocco MManuel
6Song YYura
7de Maertelaer VVivianehttps://orcid.org/0000-0001-6722-7267
8Moers VVirginie
9Latil MMathilde
10Dubois CChristine
11Coulonval KKatia
12Impens FFrancishttps://orcid.org/0000-0003-2886-9616
13Van Haver DDelphihttps://orcid.org/0000-0002-4659-5631
14Dufour SSarahttps://orcid.org/0000-0003-2036-7849
15Uemura AAkiyoshihttps://orcid.org/0000-0001-5574-5470
16Sotiropoulou PAPanagiota A
17Méndez JJuanhttps://orcid.org/0000-0002-3235-2559
18Blanpain CCédrichttps://orcid.org/0000-0002-4028-4322

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Drug Resistance, NeoplasmMajor topic
Epithelial-Mesenchymal TransitionMajor topic
rho GTP-Binding ProteinsMajor topic
Skin NeoplasmsMajor topic
Actins
Cell Line, Tumor
Proteomics
Animals
Mice
Gene Expression Profiling
Genome

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in36949121Cancer cells remodel nuclear actin filaments to resist chemotherapy.https://conductscience.org/library/papers/36949121PubMed
Comment in37106250EMT in chemoresistance.https://conductscience.org/library/papers/37106250PubMed

Download CSV of comments and corrections

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127831506Causes of death among cancer patients.Ann Oncol2017https://conductscience.org/library/papers/27831506PubMed
229326430EMT in cancer.Nat Rev Cancer2018https://conductscience.org/library/papers/29326430PubMed
328397828EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.Nat Rev Clin Oncol2017https://conductscience.org/library/papers/28397828PubMed
427368099EMT: 2016.Cell2016https://conductscience.org/library/papers/27368099PubMed
524875735Oncogenic roles of EMT-inducing transcription factors.Nat Cell Biol2014https://conductscience.org/library/papers/24875735PubMed
619336515Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells.Clin Cancer Res2009https://conductscience.org/library/papers/19336515PubMed
725086746ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.Nat Cell Biol2014https://conductscience.org/library/papers/25086746PubMed
826560028Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.Nature2015https://conductscience.org/library/papers/26560028PubMed
926560033Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.Nature2015https://conductscience.org/library/papers/26560033PubMed
1027889319Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition.Cell Stem Cell2017https://conductscience.org/library/papers/27889319PubMed
1134902824NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.J Natl Compr Canc Netw2021https://conductscience.org/library/papers/34902824PubMed
1229670281Identification of the tumour transition states occurring during EMT.Nature2018https://conductscience.org/library/papers/29670281PubMed
1322971344RhoJ regulates melanoma chemoresistance by suppressing pathways that sense DNA damage.Cancer Res2012https://conductscience.org/library/papers/22971344PubMed
1428753606The RhoJ-BAD signaling network: An Achilles' heel for BRAF mutant melanomas.PLoS Genet2017https://conductscience.org/library/papers/28753606PubMed
1532984327MKL1 Mediates TGF-β Induced RhoJ Transcription to Promote Breast Cancer Cell Migration and Invasion.Front Cell Dev Biol2020https://conductscience.org/library/papers/32984327PubMed
1621148427RhoJ/TCL regulates endothelial motility and tube formation and modulates actomyosin contractility and focal adhesion numbers.Arterioscler Thromb Vasc Biol2011https://conductscience.org/library/papers/21148427PubMed
1732822001Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics.Neurotherapeutics2020https://conductscience.org/library/papers/32822001PubMed
1821363960Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications.Genes Dev2011https://conductscience.org/library/papers/21363960PubMed
1910967094Characterization of TCL, a new GTPase of the rho family related to TC10 andCcdc42.J Biol Chem2000https://conductscience.org/library/papers/10967094PubMed
2026166705BOD1L Is Required to Suppress Deleterious Resection of Stressed Replication Forks.Mol Cell2015https://conductscience.org/library/papers/26166705PubMed

See all 63 referencesDownload CSV of references

Cited by134

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 179 citations.

PMIDTitleJournalYearIn PapersSource
429198643D tissue model to patient atlas: dynamic network topology reveals PDAC chemoresistance bottlenecks.NPJ Syst Biol Appl2026https://conductscience.org/library/papers/42919864PubMed
42860404Targeting receptor tyrosine kinases: from molecular mechanisms to clinical therapeutics.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42860404PubMed
42807396Bioactive Constituents of Ginseng in Cancer Therapy: Molecular Mechanisms, Translational Potential, and Advanced Delivery Strategies.Int J Biol Sci2026https://conductscience.org/library/papers/42807396PubMed
42748914Single-cell and spatial multi-omics reveal a recurrent multicellular niche at the tumor-stroma interface in multidrug resistance.Cell Rep Med2026https://conductscience.org/library/papers/42748914PubMed
42613325Role of epithelial-mesenchymal transition (EMT) in malignancies: current status and future prospects.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42613325PubMed
42602989Adaptive epithelial-mesenchymal bi-directional transition: A key invasive plasticity for tumor metastasis.iScience2026https://conductscience.org/library/papers/42602989PubMed
42583543LTB4R inhibits apoptosis and induces radiosensitivity by promoting the PI3K/AKT pathway in esophageal squamous cell carcinoma.J Thorac Dis2026https://conductscience.org/library/papers/42583543PubMed
42565737Multi-Omics Analysis Identifies Tryptophan Metabolism and Glycolysis as Potential Pathways Involved in the Protective Effects of Tormentic Acid Against Metabolic Associated Fatty Liver Disease.Pharmacol Res Perspect2026https://conductscience.org/library/papers/42565737PubMed
42554156Immunohistochemical Expression of RhoJ Protein in Breast Carcinoma.Appl Immunohistochem Mol Morphol2026https://conductscience.org/library/papers/42554156PubMed
42543381Cancer drug response and resistance: molecular mechanisms and combating strategies.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42543381PubMed
42333231Pan-cancer signaling landscape linked to endothelial and immune Sphingosine-1-phosphate receptor 1 (S1PR1) expression.In Silico Pharmacol2026https://conductscience.org/library/papers/42333231PubMed
42277016Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer.Nat Commun2026https://conductscience.org/library/papers/42277016PubMed
42230580C/EBPγ induces epithelial-mesenchymal transition and facilitates DNA double-strand break repair in lung adenocarcinoma cells.Cell Death Discov2026https://conductscience.org/library/papers/42230580PubMed
42203766Recurrence in the chemotherapy regimen of bladder carcinoma originates from quiescent epidermoid-like cells.Nat Commun2026https://conductscience.org/library/papers/42203766PubMed
42182196Bound for the nucleus: defining the molecular principles of cargo selection by importin 9.bioRxiv2026https://conductscience.org/library/papers/42182196PubMed
42143069Disrupting SOX2 self-association and condensate formation to overcome chemotherapeutic drug resistance in lung squamous cell carcinoma.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42143069PubMed
42106340SPOP-mediated K27-linked non-degradative ubiquitination of KCNN3 suppressing HCC progression via the CTCF-SATB1 axis.Cell Death Dis2026https://conductscience.org/library/papers/42106340PubMed
42093646Rho GTPases in cancer resistance: mechanisms, vulnerabilities, and therapeutic opportunities.Biochem Soc Trans2026https://conductscience.org/library/papers/42093646PubMed
42082974Transforming tumor microenvironments: nanotechnology and gene therapy in cellular signaling and epigenetic insight into chemo-resistance.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/42082974PubMed
42050207HDAC8-mediated CAPZB desuccinylation enhances cytoskeleton remodeling to promote idiopathic pulmonary fibrosis.Commun Biol2026https://conductscience.org/library/papers/42050207PubMed

See all 134 cited byDownload CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36949199

GET https://conductscience.org/api/papers/v1/36949199/references?page=2